Minerva Neurosciences to Present at JMP Securities Life Sciences Conference
WALTHAM, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the JMP Securities 2019 Life Sciences Conference on June 19, 2019 at 9:30 a.m. Eastern Time.
The presentation will be webcast and accessible through the investor relations section of the Company’s web site, http://ir.minervaneurosciences.com.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat CNS diseases. Minerva’s proprietary compounds include: roluperidone (MIN-101), in clinical development for schizophrenia; seltorexant (MIN-202 or JNJ-42847922), in clinical development for insomnia and major depressive disorder (MDD); MIN-117, in clinical development for MDD; and MIN-301, in pre-clinical development for Parkinson’s disease. Minerva’s common stock is listed on the NASDAQ Global Market under the symbol “NERV.” For more information, please visit www.minervaneurosciences.com.
William B. Boni
VP, Investor Relations
Minerva Neurosciences, Inc.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso15.10.2019 10:30:00 CEST | Press release
Metso Corporation, Stock exchange release on October 15, 2019, at 11:30 a.m. EET Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the holding of mutual funds managed by BlackRock, Inc. of the total amount of shares and financial instruments entitling to shares of Metso. On October 11, 2019, BlackRock, Inc.'s holding in Metso shares and in financial instruments entitling to shares exceeded the 5 percent threshold. BlackRock, Inc. had 7,245,872 shares or 4.81 percent of total shares and votes. Its holding through financial instruments amounted to 363,581 shares, which corresponds to 0.24 percent of the total amount of Metso’s shares. On October 11, 2019, BlackRock, Inc.'s total position in Metso amounted to 7,609,453 or 5.06 percent of Metso’s shares and votes. Metso’s total numbe
Result of Riksbank certificate sale15.10.2019 10:15:00 CEST | Press release
CERTIFICATE MATURITY 191023 FIXED RATE -0.25 % OFFERED VOLUME 389.000 BLN TOTAL BID AMOUNT 429.500 BLN ACCEPTED VOLUME 389.000 BLN PERCENTAGE ALLOTTED 90.5700 % NUMBER OF BIDS 10 DEPOSIT RATE -0.35 % LENDING RATE 0.50 %
Conditions for sale of Riksbank certificates15.10.2019 09:30:00 CEST | Press release
AUCTION DATE: OCT 15, 2019 START DATE: OCT 16, 2019 MATURITY DATE: OCT 23, 2019 NOMINAL AMOUNT: 389.0 BLN FIXED RATE: -0.25 % PROJECTED LIQUIDITY SURPLUS FOR THE PERIOD OCT 16-23 2019: 434 BLN SEK. AT FULL ALLOTMENT EXCESS LIQUIDITY WILL AMOUNT TO APPROXIMATELY 45 BLN SEK FOR THE PERIOD OCT 16-23 2019. ALL MONETARY POLICY COUNTERPARTIES ARE INVITED TO SUBMIT BIDS TO THE RIKSBANK (08-6966970) BY 10.00 AM ON OCT 15 2019, AT THE LATEST. CONFIRMATION OF BIDS TO E-MAIL: RBCERT@riksbank.se THE LOWEST ACCEPTED BID VOLUME IS SEK 1 MLN. THE HIGHEST ACCEPTED BID VOLUME IS SEK 389.0 BLN. RESULT OF AUCTION WILL BE PUBLISHED AT 10.15 (CEST) ON OCT 15, 2019. COMPLETE TERMS AND CONDITIONS CAN BE RETRIEVED AT WWW.RIKSBANK.SE
RCI Banque discloses binding MREL requirement15.10.2019 09:23:00 CEST | Press release
October 15th, 2019 RCI Banque discloses binding MREL(1) requirement RCI Banque has received the draft notification from the Single Resolution Board (SRB) of its binding minimum requirement for own funds and eligible liabilities (MREL). The requirement is in line with our expectations and RCI Banque made the decision not to exercise its « right to be heard ». This MREL requirement has been set at 7.35% of the total liabilities and own funds (TLOF). This is equivalent to 12.27% of RCI Banque’s risk weighted assets (RWA) and has been calibrated based on 2017 Overall Capital Requirement. As of today, RCI Banque already complies with this MREL requirement. Future requirements will be subject to ongoing review. ------------------- (1) MREL: Minimum Requirement for own funds and Eligible Liabilities. The Bank Recovery and Resolution Directive (BRRD) requires European banks to maintain a minimum amount of Own Funds and Eligible Liabilities that could absorb losses and allow them to restore the
In September revenues increased by 30%, substantial increase in all major markets15.10.2019 08:44:00 CEST | Press release
JSC Olainfarm preliminary consolidated results for September 2019 indicate that revenues increased by 30% compared to the same month last year and reached 12.4 million euro. At the same time consolidated results for the first nine months of 2019 show that revenues reached 98.8 million euro which is an increase by 11%, compared to the nine-month period of 2018. Extraordinary rapid increase in sales was in Ukraine, Kazakhstan and Uzbekistan markets. Products of Olainfarm Group during this period were sold in 54 markets worldwide. Consolidated sales in September show revenue increase in all of the main markets. In Russia sales grew by 21%, in Latvia by 9%, in Belarus by 67%, in Ukraine by 137%, in Kazakhstan by 823%, in Moldova by 46%, in Uzbekistan by 542%, in Lithuania by 63% and in Poland by 45%. Brazil was among the largest markets where products were sold in amount of 151 thousand EUR. In the nine months of 2019, the main sales markets of Olainfarm Group continued to contribute 78% o
Better Collective’s nomination committee appointed15.10.2019 08:30:00 CEST | Press release
Regulatory release 31/2019 Better Collective, the world’s leading developer of digital platforms for bookmaker information, iGaming communities, and betting tips, has appointed its nomination committee, based on ownership data as per August 31, 2019. Better Collective’s nomination committee shall consist of four members, representing the three largest shareholders as per the end of August each year, together with the chairman of the board of directors. On August 31, 2019, the three largest shareholders were Chr. Dam Holding, J. Søgaard Holding, and Bumble Ventures which due to their interlinked ownership are grouped. In accordance with shareholders’ decision, the nomination committee has been appointed and is composed by four members in total: Daniel Nyvang Mariussen, chairman, appointed by Chr. Dam Holding, J. Søgaard Holding, and Bumble Ventures Martin Jonasson, appointed by Andra AP-Fonden Michael Knutsson, appointed by Knutsson Holdings Jens Bager, Chairman of the board of director